An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, and Center for Brain Research in Mood Disorders, Washington University School of Medicine, St. Louis, Missouri 63110 zorumskc@wustl.edu.
2 Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, and Center for Brain Research in Mood Disorders, Washington University School of Medicine, St. Louis, Missouri 63110.
1 Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, and Center for Brain Research in Mood Disorders, Washington University School of Medicine, St. Louis, Missouri 63110 zorumskc@wustl.edu.
2 Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, and Center for Brain Research in Mood Disorders, Washington University School of Medicine, St. Louis, Missouri 63110.
Human studies examining the effects of the dissociative anesthetic ketamine as a model for psychosis and as a rapidly acting antidepressant have spurred great interest in understanding ketamine's actions at molecular, cellular, and network levels. Although ketamine has unequivocal uncompetitive inhibitory effects on N-methyl-d-aspartate receptors (NMDARs) and may preferentially alter the function of NMDARs on interneurons, recent work has questioned whether block of NMDARs is critical for its mood enhancing actions. In this viewpoint, we examine the evolving literature on ketamine supporting NMDARs as important triggers for certain psychiatric effects and the possibility that the antidepressant trigger is unrelated to NMDARs. The rapidly evolving story of ketamine offers great hope for untangling and treating the biology of both depressive and psychotic illnesses.
Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015;66:509–523. doi: 10.1146/annurev-med-053013-062946.
-
DOI
-
PMC
-
PubMed
Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br J Pharmacol. 1983;79:565–575. doi: 10.1111/j.1476-5381.1983.tb11031.x.
-
DOI
-
PMC
-
PubMed
Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM. NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses. Nature. 2011;475:91–95. doi: 10.1038/nature10130.
-
DOI
-
PMC
-
PubMed
Baker SC, Shabir S, Georgopoulos NT, Southgate J. Ketamine-induced apoptosis in normal human urothelial cells: a direct, N-methyl-d-aspartate receptor-independent pathway characterized by mitochondrial stress. Am J Pathol. 2016;186:1267–1277. doi: 10.1016/j.ajpath.2015.12.014.
-
DOI
-
PMC
-
PubMed
Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL. Ketamine-induced loss of phenotype of fast spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–1647. doi: 10.1126/science.1148045.
-
DOI
-
PubMed